Arcturus Therapeutics (ARCT) announced the appointment of Moncef Slaoui as chair designate. Slaoui has been serving on the company’s board of directors since June 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
